Although risk factors for recurrence have been identified, including microvascular invasion, alpha-fetoprotein (AFP) levels, and tumor grade, no simple-to-implement risk score is available that could help guide organ allocation away from those patients likely to experience HCC recurrence or to identify patients likely to benefit from intensive surveillance strategies or adjuvant therapies. Here, AFP is linked to hepatocellular carcinoma.